AP
Acurx Pharmaceuticals, Inc.
SEC filingPharmaceuticals · Staten Island, NY
Amount raised$4.6Msold at filing
Total offering$4.6M
Investors in the raise5count reported to the SEC
FiledApr 29, 2026first sale Apr 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jack H. DeanDirector
James H. DonohueDirector
Thomas H. HarrisonDirector
Robert J. DeLucciaExecutive Officer, Director
Joseph H. ScodariDirector
Carl H. SailerDirector
Robert G. ShawahExecutive Officer
David P. LuciExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.